Testing Nervoheel N to treat mild nervous disorders
Nervoheel N is a homeopathic preparation used to treat psychosomatic disorders, climacteric neurosis, and emotional distress
In this study, it’s reported to be as effective as lorazepam (Ativan).
First, the details.
- 248 patients with insomnia, distress, anxieties, restlessness or burnout and similar nervous conditions (?mild nervous disorders?) were treated with Nervoheel N or lorazepam at recommended doses for up to 4 weeks.
- Dose variations were allowed if in the patient’s best interest.
- Treatment effects were evaluated by the practitioner in dialogue with the patient at the start of treatment, after 2 weeks and after maximally 4 weeks.
- There was no attempt to randomly assign patients to treatment or conceal the treatment given.
And, the results.
- Both treatment groups reported significant symptomatic improvements.
- Differences between the groups were not significant.
- Both treatments were well tolerated, with few adverse events and good self-assessed tolerability.
The bottom line?
The authors conclude, “In patients who opt for a homeopathic treatment regimen for the short-term relief of mild nervous disorders, the effects of Nervoheel N are non-inferior to those of lorazepam.”
But wait.
Ativan is FDA-approved only for the management of anxiety or anxiety associated with depressive symptoms. It is not approved to treat insomnia, distress, restlessness, or burnout and similar “nervous conditions.”
Was this a fair comparison?
The study is open to additional criticism.
- Broad, poorly defined conditions were treated.
- Lack or random assignment of treatment
- No blinding of the patients or doctors to the treatment
- Lack of independent assessment of outcomes.
Except for the last criticism, this study could have been better for little if any increase in cost.
11/23/07 20:23 JR